Literature DB >> 26241340

Acidic FGF promotes neurite outgrowth of cortical neurons and improves neuroprotective effect in a cerebral ischemic rat model.

M J Tsai1, S K Tsai2, M C Huang3, D Y Liou4, S L Huang5, W H Hsieh6, W C Huang7, S S Huang8, H Cheng9.   

Abstract

Acidic fibroblast growth factor (aFGF) is a neurotrophic factor which is a powerful neuroprotective and neuroregenerative factor of the nervous system. Prior study had shown that levels of FGFs significantly increase following ischemic injury, reflecting a physiological protection mechanism. However, few reports demonstrated the efficacy of applying aFGF in cerebral ischemia. A recent report showed that the intranasal aFGF treatment improved neurological functional recovery; however, it did not significantly reduce the lesion size in ischemic rats. The present study examines the neuroprotective effect of aFGF on cortical neuron-glial cultures under oxygen glucose deprivation (OGD)-induced cell damage and investigates whether epidural application of slow-released aFGF could improve benefit on ischemic stroke injury in conscious rats. We used a topical application of aFGF mixed in fibrin glue, a slow-release carrier, over the peri-ischemic cortex and examined such treatment on cerebral infarction and behavioral impairments of rats subjected to focal cerebral ischemia (FCI). Results demonstrate that aFGF effectively protected cortical neuron-glial cultures from OGD-induced neuronal damage. Neurite extension from cortical neurons was significantly enhanced by aFGF, mediated through activation of AKT and ERK. In addition, topical application of fibrin glue-mixed aFGF dose-dependently reduced ischemia-induced brain infarction and improved functional restoration in ischemic stroke rats. Slow-released aFGF not only protected hippocampal and cortical cell loss but reduced microglial infiltration in FCI rats. Our results suggest that aFGF mixed in fibrin glue could prolong the protective/regenerative efficacy of aFGF to the damaged brain tissue and thus improve the functional restorative effect of aFGF.
Copyright © 2015 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Akt; ERK; aFGF; cortical neuronal cultures; ischemic stroke; neuroprotection

Mesh:

Substances:

Year:  2015        PMID: 26241340     DOI: 10.1016/j.neuroscience.2015.07.074

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  18 in total

1.  Pharmacokinetic Study of Piracetam in Focal Cerebral Ischemic Rats.

Authors:  Pankaj Paliwal; Debabrata Dash; Sairam Krishnamurthy
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2018-04       Impact factor: 2.441

2.  Regionally specified human pluripotent stem cell-derived astrocytes exhibit different molecular signatures and functional properties.

Authors:  Robert A Bradley; Jack Shireman; Caya McFalls; Jeea Choi; Scott G Canfield; Yi Dong; Katie Liu; Brianne Lisota; Jeffery R Jones; Andrew Petersen; Anita Bhattacharyya; Sean P Palecek; Eric V Shusta; Christina Kendziorski; Su-Chun Zhang
Journal:  Development       Date:  2019-07-08       Impact factor: 6.868

3.  Fibroblast Growth Factor 1-Transfected Adipose-Derived Mesenchymal Stem Cells Promote Angiogenic Proliferation.

Authors:  Seyed Javad Hoseini; Hamed Ghazavi; Fatemeh Forouzanfar; Baratali Mashkani; Ahmad Ghorbani; Elahe Mahdipour; Faezeh Ghasemi; Hamid Reza Sadeghnia; Majid Ghayour-Mobarhan
Journal:  DNA Cell Biol       Date:  2017-03-10       Impact factor: 3.311

4.  Indole-3-carbinol improves neurobehavioral symptoms in a cerebral ischemic stroke model.

Authors:  Pankaj Paliwal; Gaurav Chauhan; Deepa Gautam; Debabrata Dash; Shashikant C U Patne; Sairam Krishnamurthy
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-03-30       Impact factor: 3.000

Review 5.  Roles of Fibroblast Growth Factors and Their Therapeutic Potential in Treatment of Ischemic Stroke.

Authors:  Confidence Dordoe; Keyang Chen; Wenting Huang; Jun Chen; Jian Hu; Xue Wang; Li Lin
Journal:  Front Pharmacol       Date:  2021-04-22       Impact factor: 5.810

Review 6.  Fibroblast Growth Factor Signalling in the Diseased Nervous System.

Authors:  Lars Klimaschewski; Peter Claus
Journal:  Mol Neurobiol       Date:  2021-04-15       Impact factor: 5.590

7.  Improving the regenerative potential of olfactory ensheathing cells by overexpressing prostacyclin synthetase and its application in spinal cord repair.

Authors:  May-Jywan Tsai; Chi-Ting Huang; Yong-San Huang; Ching-Feng Weng; Song-Kun Shyue; Ming-Chao Huang; Dann-Ying Liou; Yan-Ru Lin; Chu-Hsun Cheng; Huai-Sheng Kuo; Yilo Lin; Meng-Jen Lee; Wen-Hung Huang; Wen-Cheng Huang; Henrich Cheng
Journal:  J Biomed Sci       Date:  2017-05-25       Impact factor: 8.410

8.  Tat-haFGF14-154 Upregulates ADAM10 to Attenuate the Alzheimer Phenotype of APP/PS1 Mice through the PI3K-CREB-IRE1α/XBP1 Pathway.

Authors:  Tian Meng; Qin Cao; Peng Lei; Ashley I Bush; Qi Xiang; Zhijian Su; Xiang He; Jack T Rogers; Ing-Ming Chiu; Qihao Zhang; Yadong Huang
Journal:  Mol Ther Nucleic Acids       Date:  2017-05-10

Review 9.  Progress in Mesenchymal Stem Cell Therapy for Ischemic Stroke.

Authors:  Yinghan Guo; Yucong Peng; Hanhai Zeng; Gao Chen
Journal:  Stem Cells Int       Date:  2021-06-15       Impact factor: 5.443

10.  Aberrant LncRNA Expression Profile in a Contusion Spinal Cord Injury Mouse Model.

Authors:  Ya Ding; Zhiwen Song; Jinbo Liu
Journal:  Biomed Res Int       Date:  2016-09-04       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.